Influence
February 13, 2020

Regenstrief researchers leading core of national research incubator

Drs. Callahan and Torke are leading a core of a national Alzheimer's research incubator.

Regenstrief researchers Christopher M. Callahan, M.D., and Alexia M. Torke, M.D., are leading the training core of a major national research incubator with the goal of improving healthcare and quality of life for people with Alzheimer’s disease and related dementias. Dr. Callahan and Dr. Torke will develop and coordinate a two-year junior career development award program to train researchers to conduct embedded pragmatic clinical trials in people living with dementia. The scientists trained will help to develop and test solutions to improve care for the growing population of people suffering from the disease.

Read more.

Related News

photo background showing data, etc.

Regenstrief Institute will host collaborative conference to improve public health data

Due to previous year’s high demand, virtual attendance option added  The Public Health Informatics Program in the Center for

Study reports chlamydia and gonorrhea more likely to be treated per CDC guidelines in males, younger patients and individuals identifying as Black or multiracial

Study reports chlamydia and gonorrhea more likely to be treated per CDC guidelines in males, younger patients and individuals identifying as Black or multiracial

But significant numbers of those living with these diseases don’t receive this treatment INDIANAPOLIS – Chlamydia and gonorrhea are

Aaron Carroll, M.D.

Call for Papers on Artificial Intelligence Applied to Pediatric Care

Published in JAMA Pediatrics. Here is a link to the article. Regenstrief Institute author: Aaron E. Carroll, M.D., M.S.